Skip to content
HowShorted

Biolase, Inc. short interest in 2019

In 2019, Biolase, Inc.'s disclosed short interest ran from 1.99% of shares outstanding on 15 Jan 2019 to 1.52% on 31 Dec 2019, a change of -0.47 percentage points. The year's high was 7.13% on 31 Oct 2019 and its low 1.35% on 15 Nov 2019, averaging 2.31% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 67.24 days on 30 Apr 2019. Full history: Biolase, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for Biolase, Inc. in 2019

2019 in figures

Start of year
1.99% (15 Jan 2019)
End of year
1.52% (31 Dec 2019)
Change
-0.47 pp
High
7.13% (31 Oct 2019)
Low
1.35% (15 Nov 2019)
Average
2.31%
Highest days to cover
67.24 (30 Apr 2019)
SEC filings marked
9

Every report in 2019

Biolase, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 20191.99%33.71
31 Jan 20192.06%8.77
15 Feb 20192.05%4.76
28 Feb 20191.92%4.24
15 Mar 20192.11%7.13results (8-K), 10-K filed
29 Mar 20192.10%16.22
15 Apr 20192.05%22.98
30 Apr 20192.06%67.24
15 May 20192.02%29.04results (8-K), 10-Q filed
31 May 20191.91%22.12
14 Jun 20191.92%19.93
28 Jun 20192.00%3.53
15 Jul 20192.16%8.15
31 Jul 20192.17%30.92
15 Aug 20192.14%26.74results (8-K), 10-Q filed
30 Aug 20192.40%16.75
13 Sep 20192.68%11.46
30 Sep 20193.19%12.97
15 Oct 20193.45%7.16
31 Oct 20197.13%5.05results (8-K)
15 Nov 20191.35%3.37results (8-K), 10-Q filed
29 Nov 20191.58%5.35
13 Dec 20191.55%2.81
31 Dec 20191.52%3.79

See also: Biolase, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.